These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 2129808)
1. Enzymes degrading bacterial chemotactic F-met peptides in human ileal and colonic mucosa. Chadwick VS; Schlup MM; Cooper BT; Broom MF J Gastroenterol Hepatol; 1990; 5(4):375-81. PubMed ID: 2129808 [TBL] [Abstract][Full Text] [Related]
2. Postheparin plasma diamine oxidase in health and intestinal disease. Rokkas T; Vaja S; Murphy GM; Dowling RH Gastroenterology; 1990 Jun; 98(6):1493-501. PubMed ID: 2110916 [TBL] [Abstract][Full Text] [Related]
3. Bacterial chemotactic oligopeptides and the intestinal mucosal barrier. Ferry DM; Butt TJ; Broom MF; Hunter J; Chadwick VS Gastroenterology; 1989 Jul; 97(1):61-7. PubMed ID: 2498147 [TBL] [Abstract][Full Text] [Related]
4. Colonic ornithine decarboxylase in inflammatory bowel disease: ileorectal activity gradient, guanosine triphosphate stimulation, and association with epithelial regeneration but not the degree of inflammation and clinical features. Allgayer H; Roisch U; Zehnter E; Ziegenhagen DJ; Dienes HP; Kruis W Dig Dis Sci; 2007 Jan; 52(1):25-30. PubMed ID: 17171446 [TBL] [Abstract][Full Text] [Related]
5. The chemotactic peptide N-formyl methionyl-leucyl-phenylalanine increases mucosal permeability in the distal ileum of the rat. von Ritter C; Sekizuka E; Grisham MB; Granger DN Gastroenterology; 1988 Sep; 95(3):651-6. PubMed ID: 2840319 [TBL] [Abstract][Full Text] [Related]
6. Role of alkaline phosphatase in colitis in man and rats. Tuin A; Poelstra K; de Jager-Krikken A; Bok L; Raaben W; Velders MP; Dijkstra G Gut; 2009 Mar; 58(3):379-87. PubMed ID: 18852260 [TBL] [Abstract][Full Text] [Related]
7. Purification and characterization of enzymes involved in the degradation of chemotactic N-formyl peptides. Nguyen KT; Pei D Biochemistry; 2005 Jun; 44(23):8514-22. PubMed ID: 15938642 [TBL] [Abstract][Full Text] [Related]
8. Proteolytic enzymes of human intestinal mucosa in non-malignant diseases of the ileum and colon. Goldberg DM; McAllister RA; Roy AD Br J Exp Pathol; 1969 Jun; 50(3):241-9. PubMed ID: 5792899 [TBL] [Abstract][Full Text] [Related]
10. Increased group II phospholipase A2 in colonic mucosa of patients with Crohn's disease and ulcerative colitis. Minami T; Tojo H; Shinomura Y; Matsuzawa Y; Okamoto M Gut; 1994 Nov; 35(11):1593-8. PubMed ID: 7828979 [TBL] [Abstract][Full Text] [Related]
11. Radio-immunoassay for formyl methionyl leucyl phenylalanine. II. Demonstration of an enterohepatic circulation of immunoreactive bacterial chemotactic peptides in man. Roberts EC; Hobson CH; Anderson RP; Chadwick VS J Gastroenterol Hepatol; 1990; 5(1):38-43. PubMed ID: 2103382 [TBL] [Abstract][Full Text] [Related]
12. Radio-immunoassay for formyl methionyl leucyl phenylalanine. I. Development and application to assessment of chemotactic peptide production by enteric bacteria. Hobson CH; Roberts EC; Broom MF; Mellor DM; Sherriff RM; Chadwick VS J Gastroenterol Hepatol; 1990; 5(1):32-7. PubMed ID: 2129421 [TBL] [Abstract][Full Text] [Related]
13. Inverse expression of prostaglandin E2-related enzymes highlights differences between diverticulitis and inflammatory bowel disease. Dai L; King DW; Perera DS; Lubowski DZ; Burcher E; Liu L Dig Dis Sci; 2015 May; 60(5):1236-46. PubMed ID: 25666316 [TBL] [Abstract][Full Text] [Related]
14. ATF4 Deficiency Promotes Intestinal Inflammation in Mice by Reducing Uptake of Glutamine and Expression of Antimicrobial Peptides. Hu X; Deng J; Yu T; Chen S; Ge Y; Zhou Z; Guo Y; Ying H; Zhai Q; Chen Y; Yuan F; Niu Y; Shu W; Chen H; Ma C; Liu Z; Guo F Gastroenterology; 2019 Mar; 156(4):1098-1111. PubMed ID: 30452920 [TBL] [Abstract][Full Text] [Related]
15. Increased neutrophil receptors for and response to the proinflammatory bacterial peptide formyl-methionyl-leucyl-phenylalanine in Crohn's disease. Anton PA; Targan SR; Shanahan F Gastroenterology; 1989 Jul; 97(1):20-8. PubMed ID: 2542118 [TBL] [Abstract][Full Text] [Related]
16. Expression of heat shock protein 32 (hemoxygenase-1) in the normal and inflamed human stomach and colon: an immunohistochemical study. Barton SG; Rampton DS; Winrow VR; Domizio P; Feakins RM Cell Stress Chaperones; 2003; 8(4):329-34. PubMed ID: 15115285 [TBL] [Abstract][Full Text] [Related]
17. Glucosamine synthetase activity of the colonic mucosa in ulcerative colitis and Crohn's disease. Goodman MJ; Kent PW; Truelove SC Gut; 1977 Mar; 18(3):219-28. PubMed ID: 852752 [TBL] [Abstract][Full Text] [Related]
18. Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria. Macpherson A; Khoo UY; Forgacs I; Philpott-Howard J; Bjarnason I Gut; 1996 Mar; 38(3):365-75. PubMed ID: 8675088 [TBL] [Abstract][Full Text] [Related]
19. Faecal mucus degrading glycosidases in ulcerative colitis and Crohn's disease. Rhodes JM; Gallimore R; Elias E; Allan RN; Kennedy JF Gut; 1985 Aug; 26(8):761-5. PubMed ID: 2991089 [TBL] [Abstract][Full Text] [Related]
20. High expression of the "A Disintegrin And Metalloprotease" 19 (ADAM19), a sheddase for TNF-α in the mucosa of patients with inflammatory bowel diseases. Franzè E; Caruso R; Stolfi C; Sarra M; Cupi ML; Ascolani M; Sedda S; Antenucci C; Ruffa A; Caprioli F; MacDonald TT; Pallone F; Monteleone G Inflamm Bowel Dis; 2013 Mar; 19(3):501-11. PubMed ID: 23429442 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]